Literature DB >> 6583307

Quantitative assessments of gait and mobility in Parkinson's disease.

G M Stern, S E Franklyn, F J Imms, S P Prestidge.   

Abstract

Gait and mobility of 50 Parkinsonian patients were studied using an instrumented walkway and by analysis of video tape. Whilst walking velocities did not differ from those of subjects with other conditions affecting gait, worsening of the patients' clinical condition was related to deterioration of scores in these objective tests.

Entities:  

Mesh：

Year:  1983        PMID： 6583307

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN： 0303-6995


  6 in total

1.  Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson's disease.

Authors:  H Stolze; J P Kuhtz-Buschbeck; H Drücke; K Jöhnk; M Illert; G Deuschl
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-03       Impact factor: 10.154

2.  Investigating body motion patterns in patients with Parkinson's disease using matching pursuit algorithm.

Authors:  M Sekine; M Akay; T Tamura; Y Higashi; T Fujimoto
Journal:  Med Biol Eng Comput       Date:  2004-01       Impact factor: 2.602

3.  Characteristics of the electromyographic patterns of lower limb muscles during gait in patients with Parkinson's disease when OFF and ON L-Dopa treatment.

Authors:  M Cioni; C L Richards; F Malouin; P J Bedard; R Lemieux
Journal:  Ital J Neurol Sci       Date:  1997-08

4.  Gait quantitation in Parkinson's disease--locomotor disability and correlation to clinical rating scales.

Authors:  P Vieregge; H Stolze; C Klein; I Heberlein
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

5.  Polestriding Intervention Improves Gait and Axial Symptoms in Mild to Moderate Parkinson Disease.

Authors:  Narayanan Krishnamurthi; Holly Shill; Darolyn O'Donnell; Padma Mahant; Johan Samanta; Abraham Lieberman; James Abbas
Journal:  Arch Phys Med Rehabil       Date:  2016-10-27       Impact factor: 3.966

6.  Ability to modulate walking cadence remains intact in Parkinson's disease.

Authors:  M E Morris; R Iansek; T A Matyas; J J Summers
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-12       Impact factor: 10.154
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.